Profile data is unavailable for this security.
About the company
PT Organon Pharma Indonesia Tbk is an independent global healthcare company. It provides pharmaceutical products for women. Its activities comprise manufacturing and processing of medicines, health/food supplements, in finished form for humans, such as in the form of tablets, capsules, ointments, powders, solutions, parental solutions, and suspensions, hormonal contraceptive drugs, production of radiopharmaceutical industry, and the pharmaceutical industry biotechnology, and industrial medical dressings, bandages, and cosmetic cotton, and wholesale trade of laboratory equipment, pharmaceutical equipment and medical equipment for humans. Its segments include manufacturing and commercial. Its diverse portfolio of women's health, biosimilars, and established brands includes therapies and products for a range of conditions and diseases. Its products include ASMANEX HFA (mometasone furoate) inhalation aerosol, for oral inhalation use; Jada System; Ganirelix Acetate Injection, and others.
- Revenue in IDR (TTM)2.76tn
- Net income in IDR106.16bn
- Incorporated1972
- Employees187.00
- LocationOrganon Pharma Indonesia Tbk PTGedung Wisma BNI 46Lantai 27 Jln Jendral Sudirman Kav.1JAKARTA SELATAN 12920IndonesiaIDN
- Phone+62 2 157897000
- Fax+62 2 131107009
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May & Baker Nigeria PLC | 256.86bn | 21.32bn | 127.01bn | 388.00 | 5.96 | 1.32 | 5.24 | 0.4945 | 1.31 | 1.31 | 15.77 | 5.89 | 1.40 | 2.88 | 20.82 | 74,767,460.00 | 11.61 | 7.20 | 18.83 | 10.73 | 31.67 | 34.45 | 8.30 | 8.37 | 0.6784 | -- | 0.3324 | -- | 37.46 | 18.16 | -27.34 | 25.88 | 13.37 | 8.45 |
| Acrux Ltd | 82.86bn | -59.35bn | 133.86bn | 43.00 | -- | 3.99 | -- | 1.62 | -0.02 | -0.02 | 0.028 | 0.0113 | 0.728 | -- | 2.61 | -- | -52.14 | -45.05 | -71.89 | -54.04 | 51.14 | -- | -71.62 | -114.01 | -- | -- | 0.5307 | -- | -32.11 | 8.91 | -659.16 | -- | -6.20 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -255.94bn | 133.97bn | 5.00 | -- | -- | -- | -- | -0.5143 | -0.5143 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -284.35 | -37.29 | -709.12 | -38.23 | -- | -- | -- | -- | -- | -- | 1.22 | -- | -- | -- | 43.40 | -- | -- | -- |
| Laboratorio Farmaceutico Erfo SpA | 95.34bn | 6.76bn | 138.85bn | 39.00 | 19.54 | 1.05 | 7.45 | 1.46 | 0.0473 | 0.0473 | 0.6665 | 0.8813 | 0.5394 | 3.09 | 8.78 | 173,045.50 | 3.83 | 13.40 | 4.69 | 16.76 | 40.54 | 51.81 | 7.11 | 21.01 | 1.51 | 23.76 | 0.0501 | -- | 24.06 | 8.62 | -22.66 | -13.88 | -- | -- |
| 1nkemia IUCT Group SA | 91.17bn | -405.98bn | 139.65bn | 45.00 | -- | -- | -- | 1.53 | -0.9012 | -0.9012 | 0.2024 | -0.2897 | 0.202 | 1.31 | 2.14 | -- | -90.11 | -31.58 | -171.35 | -71.37 | 91.46 | 102.07 | -445.97 | -198.82 | 0.264 | 3.18 | 1.74 | -- | 1.68 | -40.67 | 95.72 | -- | -73.14 | -- |
| Oncozenge AB | 0.00 | -16.98bn | 140.63bn | -- | -- | 6.86 | -- | -- | -1.01 | -1.01 | 0.00 | 1.21 | 0.00 | -- | -- | -- | -55.08 | -- | -59.44 | -- | -- | -- | -- | -- | -- | -2,944.50 | 0.00 | -- | -- | -- | 65.91 | -- | -- | -- |
| Organon Pharma Indonesia Tbk PT | 2.76tn | 106.16bn | 142.82bn | 187.00 | -- | -- | 0.9947 | 0.0517 | 29,488.80 | 29,488.80 | 767,296.60 | 283,451.20 | 1.68 | 5.89 | 4.98 | 13,880,730,000.00 | 6.47 | 11.41 | 9.80 | 15.86 | 7.49 | 12.57 | 3.84 | 6.78 | 1.35 | 43.76 | 0.004 | -- | 17.45 | 4.49 | 7.39 | 8.11 | -14.93 | -- |
| Cytophage Technologies Ltd | 0.00 | -87.95bn | 142.94bn | -- | -- | 2.40 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
